These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 21893987)
1. Endothelin and the renal vasculature. Guan Z; Inscho EW Contrib Nephrol; 2011; 172():35-49. PubMed ID: 21893987 [TBL] [Abstract][Full Text] [Related]
2. Role of endothelin in the control of peripheral vascular tone in human hypertension. Taddei S; Virdis A; Ghiadoni L; Sudano I; Magagna A; Salvetti A Heart Fail Rev; 2001 Dec; 6(4):277-85. PubMed ID: 11447302 [TBL] [Abstract][Full Text] [Related]
3. Endothelin and the renal microcirculation. Guan Z; VanBeusecum JP; Inscho EW Semin Nephrol; 2015 Mar; 35(2):145-55. PubMed ID: 25966346 [TBL] [Abstract][Full Text] [Related]
4. Endothelin as a regulator of cardiovascular function in health and disease. Haynes WG; Webb DJ J Hypertens; 1998 Aug; 16(8):1081-98. PubMed ID: 9794709 [TBL] [Abstract][Full Text] [Related]
5. Endothelin and heart failure. Nambi P; Clozel M; Feuerstein G Heart Fail Rev; 2001 Dec; 6(4):335-40. PubMed ID: 11447308 [TBL] [Abstract][Full Text] [Related]
6. Role of endothelin and endothelin receptor antagonists in renal disease. Neuhofer W; Pittrow D Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017 [TBL] [Abstract][Full Text] [Related]
7. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease. Noll G; Wenzel RR; Lüscher TF Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):259-67. PubMed ID: 8739256 [TBL] [Abstract][Full Text] [Related]
8. Role of endothelin in cardiovascular disease. Agapitov AV; Haynes WG J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741 [TBL] [Abstract][Full Text] [Related]
9. Physiological role of endothelin in cardiovascular and renal hemodynamics: studies in animals. Gellai M Curr Opin Nephrol Hypertens; 1997 Jan; 6(1):64-8. PubMed ID: 9051356 [TBL] [Abstract][Full Text] [Related]
10. Endothelin antagonists for hypertension and renal disease. Barton M; Luscher TF Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):549-56. PubMed ID: 10541216 [TBL] [Abstract][Full Text] [Related]
11. Highlights on endothelins: a review. Ortega Mateo A; de Artiñano AA Pharmacol Res; 1997 Nov; 36(5):339-51. PubMed ID: 9441724 [TBL] [Abstract][Full Text] [Related]
12. The intrarenal endothelin system and hypertension. Abassi ZA; Ellahham S; Winaver J; Hoffman A News Physiol Sci; 2001 Aug; 16():152-6. PubMed ID: 11479363 [TBL] [Abstract][Full Text] [Related]
13. Cerebral microvascular responses to endothelins: the role of ETA receptors. Sagher O; Jin Y; Thai QA; Fergus A; Kassell NF; Lee KS Brain Res; 1994 Sep; 658(1-2):179-84. PubMed ID: 7834340 [TBL] [Abstract][Full Text] [Related]
14. Endothelins in the normal and diseased kidney. Kohan DE Am J Kidney Dis; 1997 Jan; 29(1):2-26. PubMed ID: 9002526 [TBL] [Abstract][Full Text] [Related]
15. Control of the renal microvasculature by vasoactive peptides. Carmines PK; Fleming JT FASEB J; 1990 Dec; 4(15):3300-9. PubMed ID: 2147667 [TBL] [Abstract][Full Text] [Related]